Listed

Telix Pharmaceuticals Ltd

TLXNasdaqCIK 2007191HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Balance sheet

Cash and equivalents$141.9m, FY2025
Shareholders' equity$415.4m, FY2025
Line itemUnitperiod not labelled2022-12-31period not labelled2023-12-31period not labelled2024-12-31FY20252025-12-31
Cash and equivalents$m78.8Cash and equivalents, period not labelled, at 2022-12-31$78.8m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2026-02-20, accession 0001628280-26-009943.Report this figure84.3Cash and equivalents, period not labelled, at 2023-12-31$84.3m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2026-02-20, accession 0001628280-26-009943.Report this figure440Cash and equivalents, period not labelled, at 2024-12-31$440.0m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2026-02-20, accession 0001628280-26-009943.Report this figure142Cash and equivalents, FY2025, at 2025-12-31$141.9m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2026-02-20, accession 0001628280-26-009943.Report this figure
Current assets$mnot reported159Current assets, period not labelled, at 2023-12-31$158.7m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2026-02-20, accession 0001628280-26-009943.Report this figure570Current assets, period not labelled, at 2024-12-31$570.1m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2026-02-20, accession 0001628280-26-009943.Report this figure330Current assets, FY2025, at 2025-12-31$330.3m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2026-02-20, accession 0001628280-26-009943.Report this figure
Total assets$mnot reported277Total assets, period not labelled, at 2023-12-31$277.3m. XBRL concept ifrs-full:Assets. 20-F filed 2026-02-20, accession 0001628280-26-009943.Report this figure940Total assets, period not labelled, at 2024-12-31$940.4m. XBRL concept ifrs-full:Assets. 20-F filed 2026-02-20, accession 0001628280-26-009943.Report this figure1,164Total assets, FY2025, at 2025-12-31$1.16bn. XBRL concept ifrs-full:Assets. 20-F filed 2026-02-20, accession 0001628280-26-009943.Report this figure
Current liabilities$mnot reported111Current liabilities, period not labelled, at 2023-12-31$111.4m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2026-02-20, accession 0001628280-26-009943.Report this figure205Current liabilities, period not labelled, at 2024-12-31$205.1m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2026-02-20, accession 0001628280-26-009943.Report this figure232Current liabilities, FY2025, at 2025-12-31$231.6m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2026-02-20, accession 0001628280-26-009943.Report this figure
Total liabilities$mnot reported175Total liabilities, period not labelled, at 2023-12-31$174.6m. XBRL concept ifrs-full:Liabilities. 20-F filed 2026-02-20, accession 0001628280-26-009943.Report this figure587Total liabilities, period not labelled, at 2024-12-31$587.4m. XBRL concept ifrs-full:Liabilities. 20-F filed 2026-02-20, accession 0001628280-26-009943.Report this figure749Total liabilities, FY2025, at 2025-12-31$748.6m. XBRL concept ifrs-full:Liabilities. 20-F filed 2026-02-20, accession 0001628280-26-009943.Report this figure
Shareholders' equity$m54.8Shareholders' equity, period not labelled, at 2022-12-31$54.8m. XBRL concept ifrs-full:Equity. 20-F filed 2026-02-20, accession 0001628280-26-009943.Report this figure103Shareholders' equity, period not labelled, at 2023-12-31$102.6m. XBRL concept ifrs-full:Equity. 20-F filed 2026-02-20, accession 0001628280-26-009943.Report this figure353Shareholders' equity, period not labelled, at 2024-12-31$352.9m. XBRL concept ifrs-full:Equity. 20-F filed 2026-02-20, accession 0001628280-26-009943.Report this figure415Shareholders' equity, FY2025, at 2025-12-31$415.4m. XBRL concept ifrs-full:Equity. 20-F filed 2026-02-20, accession 0001628280-26-009943.Report this figure

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. Listed shows no prices and gives no investment advice.